Slide 1: A global survey of patients, providers, and clinic staff reveals barriers to nAMD care
DR®. A global survey of patients, providers, and clinic staff from 24 countries reveals barriers to optimal care delivery for nAMD due to constraints and gaps in clinic capacity Richard P Gale,’ Michelle Sylvanowicz,? Winfried M Amoaku,® Tariq Aslam,4 Gemmy CM Cheung,° Bora Eldem,® Robert P Finger,’
Slide 2: Financial disclosures and acknowledgments
DR. . po: nAMD £ Be ter Financial disclosures and acknowledgments nAMD 4 Overcoming Barriers Richard P Gale: Consultant/advisory boards: Allergan, Almera, Bayer, Novartis, Santen; Educational travel grants: Allergan, Bayer, Heidelberg, Novartis; Research grants: Allergan, Bayer, Novartis, Roche. Mic
Slide 3: Survey objectives and design
DR QD . . . nAMD S Be omater Survey objectives and design nAMD 4 Shifting the needle Overcoming Barriers Problem: Regular anti-VEGF treatment for nAMD frequently leads to maintenance or improvement of visual acuity;'* however, numerous factors, including the need for repeated visits, can be burdenso
Slide 4: Individual questionnaires for respondents
nAMD 4 Individual questionnaires for respondents Barometét Likert-scale questions TUUVIGtttaaiagy 16 Povou have wet AMD in both eyes? Single-choice questions
Slide 5: Global Survey: respondents for the nAMD survey
DR). . nAMD Jy DRY. Global Survey: respondents for the nAMD survey Barometer Shifting the needle vercoming Barriers Croatia Germany France Portugal Greece Switzerland = oom OE > Ee Russia 13 274 142 262 204 United Arab Saudi Emirates _|srael Arabia =. a = 18 130 21 197 ( N Mexico Turkey Kuwait i 856
Slide 6: Survey participation and analysis
DR). nAMD A, Barometer Survey participation and analysis Barometer Shifting the needle Overcoming Barriers (- > (~ >) Self-reported adherence of patients with nAMD? Data: 6425 respondents comprising: 186 _ - 4558 patients with nAMD \ * 659 providers * 1208 clinic staff = Adherent = Non-adherent = Mi
Slide 7: Do patients understand their disease and treatment?
ay) . ae nAMD DRY. Do patients understand their disease and treatment? Boomedt Shifting the needle vercoming Barriers @ Overall, 24.8% of patients said that they do 45.7% of patients said that they did not not really understand their condition ff receive clear information on what nAMD is or and/or t
Slide 8: Do patients understand their disease and treatment?
DRW. nAMD AY Barometer Do patients understand their disease and treatment? Barometér Shifting the needle vercoming Barriers @ Overall, 24.8% of patients said that they do 45.7% of patients said that they did not not really understand their condition ff receive clear information on what nAMD is or an
Slide 9: Are appropriate expectations set for our patients?
Are appropriate expectations set for our patients? nAMD 4 Overcoming Barriers As you continue with treatment, do For patients with nAMD: you expect your vision to: 0.7 338 Z 73.6% expected their vision to continue \ to improve with treatment 3.2_-4 \ 47.5% did not know how long treatment would be re
Slide 10: What are the factors causing burden to patients?
Ww . . OE ier What are the factors causing burden to patients? nAND A> Shifting the needle Overcoming Barriers Treatment and appointment burden 45.9% of patients reported that the frequency of treatment was too much 44.4% of patients were concerned about being a burden to family or friends 39.9% of
Slide 11: Opportunities identified by patients to support management of nAMD
DR. Opportunities identified by patients to niMD/> Barometer : Shifting the needle support them with the management of nAMD Overcoming Barriers Clinic processes Access to treatment Appointment reminders sent by the clinic (79.1%) Phone consultations to answer questions | may have (74.6%) My doctor p
Slide 12: How can these findings enhance patient-focused care?
DR. — ; nAMD A Barometer | How can these findings enhance patient-focused care? Barometer Shifti e needle Overcoming Barriers Sh This survey provides important and novel insights into the scale and breadth of key challenges in clinical management of nAMD as perceived by patients, providers, and clin
Slide 13: Thank you to all survey participants and centers
, .. AMD Barometer Thank you to all survey participants and centers! niMD A> e Overcoming Barriers (— Survey centers: > Australia: Sydney West Retina, Australian Eye Specialists, Retina Specialists Victoria. Brazil: Hospital Oftalmologico de Sorocaba, Hospital de Olhos de Araraquara, Centro de Refer